|
2025
|
P/S
|
Pharmaceutical and Medicinal Preparations |
|
2024
|
P/S
|
Pharmaceuticals; Medicinal preparations and substances; Medical preparations; Medicine; Medicines... |
|
|
Invention
|
Pharmaceutical compositions for minocycline.
The present application relates to a method of oral... |
|
|
P/S
|
Non-medicated cosmetics and toiletry preparations; Non-medicated dentifrices; Perfumery, essentia... |
|
|
P/S
|
Cosmetics; hair lotions; soaps; shampoo; perfumery; essential oils; dentifrices; Deodorant for pe... |
|
|
Invention
|
Amorphous solid dispersion of fruquintinib. The present application provides an amorphous solid d... |
|
|
Invention
|
Crystalline forms of danuglipron. The present application relates to novel crystalline forms of D... |
|
|
Invention
|
Method for identification and quantification of analytes by mass spectrometry. The present invent... |
|
|
Invention
|
Pharmaceutical compositions of nilotinib. The present invention relates to immediate release phar... |
|
|
Invention
|
Nutraceutical composition for oral administration. The present application relates to a oral comp... |
|
|
Invention
|
A process to produce a pharmaceutical composition. The present invention relates to a mammalian c... |
|
|
Invention
|
Solid state forms of pirtobrutinib and process for the preparation of intermediate thereof. SS)-2... |
|
|
Invention
|
Hairfall control shampoo. The present invention relates to an improved hair care shampoo composit... |
|
2023
|
Invention
|
Process for preparation of niraparib tosylate and its intermediates. The present application rela... |
|
|
Invention
|
Process for the preparation of tirzepatide. The present application relates to processes for the ... |
|
|
Invention
|
Sustained release composition of hydroxyzine and it's process. The present invention relates to s... |
|
|
Invention
|
Improved process for the preparation of voclosporin. The present invention provides an improved p... |
|
|
P/S
|
Pharmaceuticals; Medicinal preparations and substances; Medical preparations; Migraine treatment ... |
|
|
Invention
|
Amorphous solid dispersions of evocalcet and procesess therof. Aspects of the present application... |
|
|
Invention
|
A pharmaceutical formulation of a therapeuticantibody and preparations thereof. The present inven... |
|
|
Invention
|
Method for selective reduction of disulfide bonds in an immunoglobulin. The present invention dis... |
|
|
Invention
|
Liquid injectable compositions of trilaciclib. The present invention relates to liquid injectable... |
|
|
Invention
|
Process for the preparation of tucatinib. The present application relates to process for the prep... |
|
|
Invention
|
Method to purify an antibody composition. The method disclosed in the current invention is used t... |
|
|
Invention
|
Process for preparation of pure sitagliptin and salts thereof. The present application relates to... |
|
|
Invention
|
Amorphous solid dispersions of deucravacitinib and processes for the preparation thereof. The pre... |
|
|
Invention
|
Mammalian cell culture. The present invention relates to method culturing of mammalian cells expr... |
|
2022
|
Invention
|
Topical composition comprising duloxetine or its salt and capsaicin. The present specification re... |
|
|
Invention
|
Process for preparation of relugolix and its intermediates. The present application relates to a ... |
|
|
Invention
|
Solid oral dosage forms of rabeprazole. The present invention relates to oral solid pharmaceutica... |
|
|
Invention
|
Herbal pharmaceutical composition for treatment of liver disorders. The present invention relates... |
|
|
Invention
|
A cell culture process to produce an antibody composition. The present invention relates to an an... |
|
|
Invention
|
Process to produce a pharmaceutical composition. The present invention relates to a cell culture ... |
|
|
Invention
|
Formulations of immune check point inhibitors.
The present invention relates to pharmaceutical f... |
|
|
Invention
|
Formulations of immune check point inhibitors or like.
The present invention discloses a stable ... |
|
|
Invention
|
A method of improving stability of immune check point inhibitors.
The present invention relates ... |
|
|
Invention
|
A pharmaceutical formulation of immune check point inhibitors.
The present invention relates to ... |
|
|
Invention
|
Method to obtain a purified antibody composition.
The current invention discloses a method for o... |
|
|
Invention
|
A process to produce a pharmaceutical composition.
The present invention relates to a cell cultu... |
|
|
Invention
|
Method to purify an antibody composition using cation exchange chromatography.
The method disclo... |
|
|
Invention
|
Method to control high molecular weight aggregates in an antibody composition.
The method disclo... |
|
|
Invention
|
Methods for treating inflammatory skin conditions.
The present application relates to a method o... |
|
|
Invention
|
A method of improving stability of an antibody formulation.
The present invention discloses a st... |
|
|
Invention
|
Cell culture process for fusion protein composition.
The present invention discloses a cell cult... |
|
|
Invention
|
Thiol variants and analytical methods thereof.
The free thiol group present in free cysteines in... |
|
|
Invention
|
Compositions comprising fusion protein and analytical attributes thereof.
The present invention ... |
|
|
Invention
|
Process for preparation of mavacamten and solid state forms thereof.
The present application rel... |
|
|
Invention
|
Cell culture methods.
The present invention discloses a method of cell culture for producing a f... |
|
|
Invention
|
Freeze dried antibody formulations and methods thereof.
The present invention discloses an optim... |
|
2021
|
Invention
|
Stable aqueous buffer free formulation of an integrin antibody.
The present invention discloses ... |
|
|
Invention
|
Stable therapeutic protein formulation and methods of making the same.
The present invention dis... |
|
|
Invention
|
Stable aqueous high concentration formulation of integrin antibody.
The present invention disclo... |
|
|
Invention
|
A process for the preparation of semaglutide and semapeptide.
The present application relates to... |
|
|
P/S
|
Pharmaceuticals for medical purposes; pharmaceutical and
medicinal preparations used in the trea... |
|
|
P/S
|
Pharmaceutical and medicinal preparations. |
|
|
P/S
|
Pharmaceuticals, medical and veterinary preparations;
sanitary preparations for medical purposes... |
|
|
P/S
|
Pharmaceuticals; medical preparations. |
|
|
P/S
|
Vaccines and pharmaceutical preparations. |
|
|
P/S
|
Pharmaceutical products for use to treat allergies, pain
relief, diabetes, asthma, osteoporosis,... |
|
|
Invention
|
Method of purifying an fc-fusion protein.
The present invention discloses a method for the purif... |
|
2020
|
P/S
|
Pharmaceutical preparations |
|
|
Invention
|
Stable formulation of integrin antibody.
The present invention discloses a stable pharmaceutical... |
|
|
P/S
|
Mobile telephones; computer software, recorded; computer
software, downloadable. Distribution of... |
|
|
P/S
|
Scientific, navigation, surveying, photographic,
cinematographic, optical, weighing, measuring, ... |
|
2015
|
P/S
|
Cosmetics, hair lotions, disinfectant soaps, cosmetic soaps, hand soaps, body soaps, shampoo; per... |
|
|
P/S
|
Pharmaceutical preparations for use in the treatment of allergies, diabetes, asthma, osteoporosis... |
